Skip to main content
. 2012 May 1;5(2):59–65.

Table 1.

Characteristics of recipients

Present
condition
Follow-up duration (month) Treat Group* Tx Pre-operative diagnosis Sex Age
Alive 32 2 MVTx Desmoid tumor M 30
Exp 4 3 MVTx Hepatocellular carcinoma M 35
Alive 4 2 MVTx Neuroendocrine tumor M 14
Exp 6 2 MMVTx Gastrointestinal stromal tumor F 35
Exp 5 3 MVTx Small bowel insufficiency following ex-vivo resection of pancreatic carcinoma M 47
Alive 3 3 MVTx Carcinoma of the pancreas M 30
Alive 2 1 MMVTx Chronic rejection of first pancreas transplant F 40
Alive 17 1 MMVTx Abdominal trauma M 50
Exp 4 3 MMVTx Carcinoma of the pancreas M 39
Exp 18 1 Small intestine Bowel gangrene F 50
Alive 13 1 Small intestine Abdominal trauma M 46
Exp 10 2 MMVTx Gastrointestinal stromal tumor F 55
Exp 10 2 MVTx Neuroendocrine tumor F 32
Alive 9 1 Small intestine Bowel gangrene M 43
Alive 7 1 Small intestine Bowel gangrene M 34
Alive 6 1 MVTx Liver cirrhosis with extensive PV and SMV thrombosis M 51
Exp 3 3 MVTx Small round cell tumor M 26
Alive 3 1 MMVTx Short bowel syndrome due to venous thrombosis F 29
*

Treatment group: For this classification see the text

Multivisceral transplantation

Modified multivisceral transplantation